Diego Correa

5.6k citations

60 papers · 3.8k indexed · 2 hit papers · h-index 28

Impact in

Genetics top 0.5%
- Mesenchymal stem cell research
Urology top 0.5%
- Periodontal Regeneration and Treatments

Papers in ⓘ

Genetics 32
- Mesenchymal stem cell research 32
Molecular Biology 20
- Bone Metabolism and Diseases 7
- Extracellular vesicles in disease 5

Co-authors: Arnold I. Caplan (10 shared papers)Dimitrios Kouroupis (21 shared papers)Rodrigo A. Somoza (5 shared papers)Lee D. Kaplan (12 shared papers)Thomas M. Best (11 shared papers)Jean F. Welter (2 shared papers)Steven A. Lietman (1 shared paper)Paul Lin (5 shared papers)
Journals: Frontiers in Bioengineering and Biotechnology (5 papers)Cytotherapy (5 papers)Stem Cells Translational Medicine (3 papers)Nature Reviews Drug Discovery (3 papers)Tissue Engineering Part B Reviews (2 papers)
Partner nations: United States Italy Nicaragua

In The Last Decade

Diego Correa

59 papers receiving 3.8k citations

Hit Papers

align trajectories log scale

Tissue Engineering and Cell-Based Therapies for Fractures and Bone Defects 2018 · 294 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Frontiers in Bioengineering and Biotechnology
2011 Cell stem cell

Peers

Countries citing papers authored by Diego Correa

Since Specialization

Citations

This map shows the geographic impact of Diego Correa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Correa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Correa more than expected).

Fields of papers citing papers by Diego Correa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego Correa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Correa. The network helps show where Diego Correa may publish in the future.

Co-authors

The 25 scholars most cited alongside Diego Correa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Diego Correa Line = papers co-authored together Diego Correa links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The MSC: An Injury Drugstore Cell stem cell ·Arnold I. Caplan, Diego Correa Hit paper breakdown →	2011	1226
2	Tissue Engineering and Cell-Based Therapies for Fractures and Bone Defects Frontiers in Bioengineering and Biotechnology ·Jose Perez, Dimitrios Kouroupis, Deborah J. Li, Thomas M. Best, Lee D. Kaplan, Diego Correa Hit paper breakdown →	2018	294
3	Chondrogenic Differentiation of Mesenchymal Stem Cells: Challenges and Unfulfilled Expectations Tissue Engineering Part B Reviews ·Rodrigo A. Somoza, Jean F. Welter, Diego Correa, Arnold I. Caplan	2014	262
4	PDGF in bone formation and regeneration: New insights into a novel mechanism involving MSCs Journal of Orthopaedic Research® ·Arnold I. Caplan, Diego Correa	2011	250
5	Articular cartilage repair: Current needs, methods and research directions Seminars in Cell and Developmental Biology ·Diego Correa, Steven A. Lietman	2016	135
6	Sequential exposure to fibroblast growth factors (FGF) 2, 9 and 18 enhances hMSC chondrogenic differentiation Osteoarthritis and Cartilage ·Diego Correa, Rodrigo A. Somoza, Paul Lin, Steven J. Greenberg, Eran Rom, Lori Duesler, Jean F. Welter, Avner Yayon, Arnold I. Caplan	2014	97
7	Increased Mesenchymal Stem Cell Functionalization in Three-Dimensional Manufacturing Settings for Enhanced Therapeutic Applications Frontiers in Bioengineering and Biotechnology ·Dimitrios Kouroupis, Diego Correa	2021	95
8	Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity The Journal of Cell Biology ·Eric Hesse, Hiroaki Saito, Riku Kiviranta, Diego Correa, Kei Yamana, Lynn Neff, Daniel Toben, Georg N. Duda, Azeddine Atfi, Valérie Geoffroy, William C. Horne, Roland Baron	2010	88
9	Zfp521 Is a Target Gene and Key Effector of Parathyroid Hormone-Related Peptide Signaling in Growth Plate Chondrocytes Developmental Cell ·Diego Correa, Eric Hesse, Dutmanee Seriwatanachai, Riku Kiviranta, Hiroaki Saito, Kei Yamana, Lynn Neff, Azeddine Atfi, Lucie Coillard, Despina Sitara, Yukiko Maeda, Søren Warming, Nancy A. Jenkins, Neal G. Copeland, William C. Horne, Beate Lanske, Roland Baron	2010	80
10	Mesenchymal Stem Cell Functionalization for Enhanced Therapeutic Applications Tissue Engineering Part B Reviews ·Dimitrios Kouroupis, Clara Sanjurjo‐Rodríguez, Elena Jones, Diego Correa	2018	71
11	Infrapatellar Fat Pad/Synovium Complex in Early-Stage Knee Osteoarthritis: Potential New Target and Source of Therapeutic Mesenchymal Stem/Stromal Cells Frontiers in Bioengineering and Biotechnology ·Dylan N. Greif, Dimitrios Kouroupis, Christopher J. Murdock, Anthony J. Griswold, Lee D. Kaplan, Thomas M. Best, Diego Correa	2020	69
12	Signature quality attributes of CD146+ mesenchymal stem/stromal cells correlate with high therapeutic and secretory potency Stem Cells ·Annie C. Bowles, Dimitrios Kouroupis, Melissa A. Willman, Carlotta Perucca Orfei, Ashutosh Agarwal, Diego Correa	2020	68
13	Landscape of cancer cell therapies: trends and real-world data Nature Reviews Drug Discovery ·Ana Rosa Saez-Ibañez, Samik Upadhaya, Tanya Partridge, Monica Shah, Diego Correa, Jay R. Campbell	2022	68
14	Efficient Lentiviral Transduction of Human Mesenchymal Stem Cells That Preserves Proliferation and Differentiation Capabilities Stem Cells Translational Medicine ·Paul Lin, Yuan Lin, Donald P. Lennon, Diego Correa, Mark Schluchter, Arnold I. Caplan	2012	66
15	Zfp521 antagonizes Runx2, delays osteoblast differentiation in vitro, and promotes bone formation in vivo Bone ·Meilin Wu, Eric Hesse, Frédéric Morvan, Jianping Zhang, Diego Correa, Glenn C. Rowe, Riku Kiviranta, Lynn Neff, William M. Philbrick, William C. Horne, Roland Baron	2008	63
16	Mesenchymal stem cells in the treatment of articular cartilage degeneration: New biological insights for an old-timer cell Cytotherapy ·Alessandra Colombini, Carlotta Perucca Orfei, Dimitrios Kouroupis, Enrico Ragni, Paola De Luca, Marco Viganò, Diego Correa, Laura de Girolamo	2019	58
17	Mesenchymal stem cells regulate melanoma cancer cells extravasation to bone and liver at their perivascular niche International Journal of Cancer ·Diego Correa, Rodrigo A. Somoza, Paul Lin, William P. Schiemann, Arnold I. Caplan	2015	58
18	Treatment of Chronic Diabetic Foot Ulcers with Adipose-Derived Stromal Vascular Fraction Cell Injections: Safety and Evidence of Efficacy at 1 Year Stem Cells Translational Medicine ·Michael H. Carstens, Francisco J. Quintana, Santos T. Calderwood, Juan P. Sevilla, Arlen B. Ríos, Carlos Martínez‐Rivera, Dorian W. Calero, María L. Zelaya, Nelson García, Kenneth A. Bertram, Joseph Rigdon, Severiano Dos-Anjos, Diego Correa	2021	54
19	Polybrene Inhibits Human Mesenchymal Stem Cell Proliferation during Lentiviral Transduction PLoS ONE ·Paul Lin, Diego Correa, Yuan Lin, Arnold I. Caplan	2011	53
20	Serial Transplantation and Long-term Engraftment of Intra-arterially Delivered Clonally Derived Mesenchymal Stem Cells to Injured Bone Marrow Molecular Therapy ·Paul Lin, Diego Correa, Thomas J. Kean, Amad Awadallah, James E. Dennis, Arnold I. Caplan	2013	50

About Diego Correa

Diego Correa is a scholar working on Genetics, Molecular Biology, Surgery, Oncology and Rheumatology, having authored 60 papers that have together received 3.8k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (32 papers), Osteoarthritis Treatment and Mechanisms (9 papers), Bone Metabolism and Diseases (7 papers), Tissue Engineering and Regenerative Medicine (6 papers), Diabetic Foot Ulcer Assessment and Management (5 papers), Bone health and treatments (5 papers), Extracellular vesicles in disease (5 papers) and Cancer Cells and Metastasis (4 papers). The work is most often cited by research in Genetics (1.7k citations), Urology (486 citations), Rheumatology (838 citations), Biomaterials (444 citations) and Orthopedics and Sports Medicine (270 citations). Diego Correa has collaborated with scholars based in United States, Italy and Nicaragua. Frequent co-authors include Arnold I. Caplan, Dimitrios Kouroupis, Rodrigo A. Somoza, Lee D. Kaplan, Thomas M. Best, Jean F. Welter, Steven A. Lietman, Paul Lin, Deborah J. Li and Jose Perez. Their work appears in journals such as Frontiers in Bioengineering and Biotechnology, Cytotherapy, Stem Cells Translational Medicine, Nature Reviews Drug Discovery and Tissue Engineering Part B Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact